We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
AUM
$248M
AUM Growth
+$25.2M
Cap. Flow
-$355K
Cap. Flow %
-0.14%
Top 10 Hldgs %
76.44%
Holding
367
New
28
Increased
133
Reduced
23
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 15.19%
2 Consumer Discretionary 4.63%
3 Financials 4.62%
4 Consumer Staples 2.47%
5 Industrials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BND icon
351
Vanguard Total Bond Market
BND
$157B
$72 ﹤0.01%
+1
New +$73
ESGE icon
352
iShares ESG Aware MSCI EM ETF
ESGE
$6.66B
$64 ﹤0.01%
+2
New +$63
FIS icon
353
Fidelity National Information Services
FIS
$21.8B
$57 ﹤0.01%
1
SCHP icon
354
Schwab US TIPS ETF
SCHP
$16.3B
$52 ﹤0.01%
+2
New +$53
MDYV icon
355
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.82B
$51 ﹤0.01%
1
-90
-99% -$5.88K
NIO icon
356
NIO
NIO
$11.4B
$40 ﹤0.01%
+4
New +$34
CENN icon
357
Cenntro
CENN
$8.43M
0
A icon
358
Agilent Technologies
A
$39.5B
-2,306
Closed -$319K
BIDU icon
359
Baidu
BIDU
$36.7B
-1,178
Closed -$178K
IDXX icon
360
Idexx Laboratories
IDXX
$46.3B
-800
Closed -$400K
INFY icon
361
Infosys
INFY
$50.4B
-6,400
Closed -$112K
MPWR icon
362
Monolithic Power Systems
MPWR
$67.8B
-120
Closed -$60.1K
FIRY
363
Firy Inc
FIRY
$150M
-23
Closed -$277
TMO icon
364
Thermo Fisher Scientific
TMO
$212B
-1,049
Closed -$605K
ZM icon
365
Zoom
ZM
$29.3B
-26
Closed -$1.92K
DCP
366
DELISTED
DCP Midstream, LP
DCP
-25
Closed -$1.06K
NID
367
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
-7,711
Closed -$100K

Similar funds

Kozak & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Kozak & Associates held 367 positions worth $248M, up 11% from $223M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Kozak & Associates's Q2 2023 filing shows 28 new, 133 increased, 23 reduced and 10 closed positions. Its largest new stake was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K. The largest sale was Thermo Fisher Scientific, an estimated $605K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Kozak & Associates's largest Q2 2023 buy was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K.
  • Kozak & Associates added most to iShares US Tech Independence Focused ETF in Q2 2023, an estimated $348K increase.
  • Kozak & Associates's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $421K.
  • Kozak & Associates fully exited Thermo Fisher Scientific in Q2 2023, selling an estimated $605K.
  • Kozak & Associates's ten largest holdings make up 76% of its $248M portfolio in Q2 2023.
  • Kozak & Associates opened 28 new positions and closed 10 in Q2 2023.
  • Kozak & Associates's portfolio value rose 11% quarter-over-quarter to $248M.

Based on Kozak & Associates's 13F filing for Q2 2023, filed 5 Jul 2023.